NeuroSense Therapeutics Price Chart
NeuroSense Therapeutics Volume Chart
NeuroSense Therapeutics Market Segments
Regular Trading Hours
-0.0005(-0.06%)
| Open | $0.8505 |
|---|---|
| Close | $0.8500 |
| Low | $0.8350 |
| Low Change | -0.0155 (-1.82%) |
| High | $0.8852 |
| High Change | +0.0347 (+4.08%) |
| Range | $0.0502 |
| Volume | 30.684K |
| Dollar Volume | $26.08K |
Premarket
-0.0296(-3.36%)
| Open | $0.8800 |
|---|---|
| Close | $0.8504 |
| Low | $0.8500 |
| Low Change | -0.0300 (-3.41%) |
| High | $0.8800 |
| High Change | +0.0000 (+0.00%) |
| Range | $0.0300 |
| Volume | 4.905K |
| Dollar Volume | $4.17K |
After Hours Yesterday
-0.0406(-4.58%)
| Open | $0.8856 |
|---|---|
| Close | $0.8450 |
| Low | $0.8450 |
| Low Change | -0.0406 (-4.58%) |
| High | $0.8856 |
| High Change | +0.0000 (+0.00%) |
| Range | $0.0406 |
| Volume | 1.385K |
| Dollar Volume | $1.17K |
Regular Trading Hours Yesterday
-0.0431(-4.73%)
| Open | $0.9100 |
|---|---|
| Close | $0.8669 |
| Low | $0.8410 |
| Low Change | -0.0690 (-7.58%) |
| High | $0.9100 |
| High Change | +0.0000 (+0.00%) |
| Range | $0.0690 |
| Volume | 157.66K |
| Dollar Volume | $136.68K |
Premarket Yesterday
-0.0041(-0.45%)
| Open | $0.9101 |
|---|---|
| Close | $0.9060 |
| Low | $0.8500 |
| Low Change | -0.0601 (-6.60%) |
| High | $0.9476 |
| High Change | +0.0375 (+4.12%) |
| Range | $0.0976 |
| Volume | 25.537K |
| Dollar Volume | $23.14K |
NeuroSense Therapeutics Moving Averages
| 5 Day Moving Average (SMA5) | $0.8596 |
|---|---|
| 10 Day Moving Average (SMA10) | $0.8679 |
| 20 Day Moving Average (SMA20) | $0.9066 |
| 50 Day Moving Average (SMA50) | $0.9139 |
| 100 Day Moving Average (SMA100) | $0.9784 |
| 200 Day Moving Average (SMA200) | $1.2776 |
NeuroSense Therapeutics Statistics
| Average Volume (30 Days) | — |
|---|---|
| P/E Ratio (Current) | — |
| EPS (Current) | — |
| Dividend Yield | — |
| Free Cash Flow | — |
| Cash Ratio | — |
| Current Ratio | — |
| Quick Ratio | — |
| Debt to Equity | — |
| Enterprise Value | — |
| EV to EBITDA | — |
| EV to Sales | — |
| Price to Book | — |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | — |
| Return on Assets | — |
| Return on Equity | — |
NeuroSense Therapeutics Stock Splits
There have been no stock splits for NeuroSense Therapeutics (NRSN).
NeuroSense Therapeutics Dividends
There have been no dividends for NeuroSense Therapeutics (NRSN).